Listed

Sarepta Therapeutics, Inc.

SRPTNasdaqCIK 873303HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$328.7m, Q2 FY2026
Operating income$13.3m, Q2 FY2026
Net income−$4.9m, Q2 FY2026
Sarepta Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m309Revenue, Q3 FY2023, three months to 2023-09-30$309.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure365Revenue, Q4 FY2023, three months to 2023-12-31$365.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure359Revenue, Q1 FY2024, three months to 2024-03-31$359.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure361Revenue, Q2 FY2024, three months to 2024-06-30$360.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure430Revenue, Q3 FY2024, three months to 2024-09-30$429.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure658Revenue, Q4 FY2024, three months to 2024-12-31$658.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure612Revenue, Q1 FY2025, three months to 2025-03-31$611.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure513Revenue, Q2 FY2025, three months to 2025-06-30$513.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure370Revenue, Q3 FY2025, three months to 2025-09-30$370.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure443Revenue, Q4 FY2025, three months to 2025-12-31$442.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure331Revenue, Q1 FY2026, three months to 2026-03-31$330.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure329Revenue, Q2 FY2026, three months to 2026-06-30$328.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reported309Gross profit, Q1 FY2024, three months to 2024-03-31$308.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure316Gross profit, Q2 FY2024, three months to 2024-06-30$316.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure338Gross profit, Q3 FY2024, three months to 2024-09-30$338.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure506Gross profit, Q4 FY2024, three months to 2024-12-31$505.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure474Gross profit, Q1 FY2025, three months to 2025-03-31$474.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure361Gross profit, Q2 FY2025, three months to 2025-06-30$360.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure219Gross profit, Q3 FY2025, three months to 2025-09-30$219.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(29.1)Gross profit, Q4 FY2025, three months to 2025-12-31−$29.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figurenot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m121Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$120.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure132Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$131.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure127Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$127.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure139Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$138.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure128Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$128.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure164Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$163.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure134Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$133.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure138Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$137.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure91.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$91.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure128Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$128.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure109Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$109.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure108Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$107.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Operating income$m(20.8)Operating income, Q3 FY2023, three months to 2023-09-30−$20.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure24.6Operating income, Q4 FY2023, three months to 2023-12-31$24.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure34.9Operating income, Q1 FY2024, three months to 2024-03-31$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure(0.7)Operating income, Q2 FY2024, three months to 2024-06-30−$701.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure22.2Operating income, Q3 FY2024, three months to 2024-09-30$22.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure162Operating income, Q4 FY2024, three months to 2024-12-31$161.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure(300)Operating income, Q1 FY2025, three months to 2025-03-31−$300.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure116Operating income, Q2 FY2025, three months to 2025-06-30$115.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure(103)Operating income, Q3 FY2025, three months to 2025-09-30−$103.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure(412)Operating income, Q4 FY2025, three months to 2025-12-31−$411.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure358Operating income, Q1 FY2026, three months to 2026-03-31$358.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure13.3Operating income, Q2 FY2026, three months to 2026-06-30$13.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Interest expense$m5.2Interest expense, Q3 FY2023, three months to 2023-09-30$5.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure(38.8)Interest expense, Q4 FY2023, three months to 2023-12-31−$38.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Interest expense, Q1 FY2024, three months to 2024-03-31−$4.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure4.8Interest expense, Q2 FY2024, three months to 2024-06-30$4.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure4.9Interest expense, Q3 FY2024, three months to 2024-09-30$4.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure(32.3)Interest expense, Q4 FY2024, three months to 2024-12-31−$32.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure(4.5)Interest expense, Q1 FY2025, three months to 2025-03-31−$4.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure(5.2)Interest expense, Q2 FY2025, three months to 2025-06-30−$5.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure1.9Interest expense, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(40.0)Interest expense, Q4 FY2025, three months to 2025-12-31−$40.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure(21.7)Interest expense, Q1 FY2026, three months to 2026-03-31−$21.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure(21.5)Interest expense, Q2 FY2026, three months to 2026-06-30−$21.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Income tax$m7.8Income tax, Q3 FY2023, three months to 2023-09-30$7.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure(5.3)Income tax, Q4 FY2023, three months to 2023-12-31−$5.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure5.3Income tax, Q1 FY2024, three months to 2024-03-31$5.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure7.1Income tax, Q2 FY2024, three months to 2024-06-30$7.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure0.4Income tax, Q3 FY2024, three months to 2024-09-30$395.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure12.7Income tax, Q4 FY2024, three months to 2024-12-31$12.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure64.0Income tax, Q1 FY2025, three months to 2025-03-31$64.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure(43.3)Income tax, Q2 FY2025, three months to 2025-06-30−$43.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure(14.1)Income tax, Q3 FY2025, three months to 2025-09-30−$14.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure4.6Income tax, Q4 FY2025, three months to 2025-12-31$4.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure12.2Income tax, Q1 FY2026, three months to 2026-03-31$12.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure3.1Income tax, Q2 FY2026, three months to 2026-06-30$3.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Net income$m(40.9)Net income, Q3 FY2023, three months to 2023-09-30−$40.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure45.7Net income, Q4 FY2023, three months to 2023-12-31$45.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure36.1Net income, Q1 FY2024, three months to 2024-03-31$36.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure6.5Net income, Q2 FY2024, three months to 2024-06-30$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure33.6Net income, Q3 FY2024, three months to 2024-09-30$33.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure159Net income, Q4 FY2024, three months to 2024-12-31$159.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(448)Net income, Q1 FY2025, three months to 2025-03-31−$447.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure197Net income, Q2 FY2025, three months to 2025-06-30$196.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure(50.6)Net income, Q3 FY2025, three months to 2025-09-30−$50.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(412)Net income, Q4 FY2025, three months to 2025-12-31−$412.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure331Net income, Q1 FY2026, three months to 2026-03-31$331.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure(4.9)Net income, Q2 FY2026, three months to 2026-06-30−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Diluted EPS$ per share(0.46)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figurenot reported0.37Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure0.07Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure0.34Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure1.50Diluted EPS, Q4 FY2024, three months to 2024-12-31$1.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(4.60)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$4.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure1.89Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure(0.50)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(3.93)Diluted EPS, Q4 FY2025, three months to 2025-12-31−$3.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure2.88Diluted EPS, Q1 FY2026, three months to 2026-03-31$2.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Basic EPS$ per share(0.46)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figurenot reported0.38Basic EPS, Q1 FY2024, three months to 2024-03-31$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure0.07Basic EPS, Q2 FY2024, three months to 2024-06-30$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure0.35Basic EPS, Q3 FY2024, three months to 2024-09-30$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure1.65Basic EPS, Q4 FY2024, three months to 2024-12-31$1.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(4.60)Basic EPS, Q1 FY2025, three months to 2025-03-31−$4.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure2.01Basic EPS, Q2 FY2025, three months to 2025-06-30$2.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure(0.50)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure(3.93)Basic EPS, Q4 FY2025, three months to 2025-12-31−$3.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure3.15Basic EPS, Q1 FY2026, three months to 2026-03-31$3.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure(0.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure

Balance sheet

Cash and equivalents$571.1m, Q2 FY2026
Long-term debt$847.6m, Q2 FY2026
Shareholders' equity$1.53bn, Q2 FY2026
Sarepta Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m542Cash and equivalents, Q3 FY2023, at 2023-09-30$541.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure428Cash and equivalents, FY2023, at 2023-12-31$428.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure427Cash and equivalents, Q1 FY2024, at 2024-03-31$427.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure384Cash and equivalents, Q2 FY2024, at 2024-06-30$383.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure198Cash and equivalents, Q3 FY2024, at 2024-09-30$197.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure1,103Cash and equivalents, FY2024, at 2024-12-31$1.10bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure241Cash and equivalents, Q1 FY2025, at 2025-03-31$240.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure511Cash and equivalents, Q2 FY2025, at 2025-06-30$510.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure613Cash and equivalents, Q3 FY2025, at 2025-09-30$613.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure801Cash and equivalents, FY2025, at 2025-12-31$801.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure464Cash and equivalents, Q1 FY2026, at 2026-03-31$464.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure571Cash and equivalents, Q2 FY2026, at 2026-06-30$571.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Current assets$m2,451Current assets, Q3 FY2023, at 2023-09-30$2.45bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-01, accession 0000950170-23-057414.Report this figure2,579Current assets, FY2023, at 2023-12-31$2.58bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-28, accession 0000950170-25-029973.Report this figure2,465Current assets, Q1 FY2024, at 2024-03-31$2.46bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-01, accession 0000950170-24-051234.Report this figure2,684Current assets, Q2 FY2024, at 2024-06-30$2.68bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092720.Report this figure2,685Current assets, Q3 FY2024, at 2024-09-30$2.69bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure3,073Current assets, FY2024, at 2024-12-31$3.07bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure2,433Current assets, Q1 FY2025, at 2025-03-31$2.43bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure2,657Current assets, Q2 FY2025, at 2025-06-30$2.66bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure2,722Current assets, Q3 FY2025, at 2025-09-30$2.72bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure2,538Current assets, FY2025, at 2025-12-31$2.54bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure2,310Current assets, Q1 FY2026, at 2026-03-31$2.31bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure2,224Current assets, Q2 FY2026, at 2026-06-30$2.22bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Total assets$m3,110Total assets, Q3 FY2023, at 2023-09-30$3.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0000950170-23-057414.Report this figure3,265Total assets, FY2023, at 2023-12-31$3.26bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-28, accession 0000950170-25-029973.Report this figure3,224Total assets, Q1 FY2024, at 2024-03-31$3.22bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-01, accession 0000950170-24-051234.Report this figure3,424Total assets, Q2 FY2024, at 2024-06-30$3.42bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092720.Report this figure3,600Total assets, Q3 FY2024, at 2024-09-30$3.60bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure3,963Total assets, FY2024, at 2024-12-31$3.96bn. XBRL concept us-gaap:Assets. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure3,465Total assets, Q1 FY2025, at 2025-03-31$3.47bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure3,680Total assets, Q2 FY2025, at 2025-06-30$3.68bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure3,493Total assets, Q3 FY2025, at 2025-09-30$3.49bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure3,350Total assets, FY2025, at 2025-12-31$3.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure3,179Total assets, Q1 FY2026, at 2026-03-31$3.18bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure3,189Total assets, Q2 FY2026, at 2026-06-30$3.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Current liabilities$m451Current liabilities, Q3 FY2023, at 2023-09-30$450.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-01, accession 0000950170-23-057414.Report this figure654Current liabilities, FY2023, at 2023-12-31$653.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-28, accession 0000950170-25-029973.Report this figure609Current liabilities, Q1 FY2024, at 2024-03-31$608.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-01, accession 0000950170-24-051234.Report this figure688Current liabilities, Q2 FY2024, at 2024-06-30$688.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092720.Report this figure699Current liabilities, Q3 FY2024, at 2024-09-30$699.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure732Current liabilities, FY2024, at 2024-12-31$731.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure606Current liabilities, Q1 FY2025, at 2025-03-31$605.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure920Current liabilities, Q2 FY2025, at 2025-06-30$919.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure921Current liabilities, Q3 FY2025, at 2025-09-30$921.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure1,095Current liabilities, FY2025, at 2025-12-31$1.10bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure499Current liabilities, Q1 FY2026, at 2026-03-31$499.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure503Current liabilities, Q2 FY2026, at 2026-06-30$502.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Total liabilities$m2,345Total liabilities, Q3 FY2023, at 2023-09-30$2.35bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-01, accession 0000950170-23-057414.Report this figure2,405Total liabilities, FY2023, at 2023-12-31$2.41bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-28, accession 0000950170-25-029973.Report this figure2,263Total liabilities, Q1 FY2024, at 2024-03-31$2.26bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-01, accession 0000950170-24-051234.Report this figure2,347Total liabilities, Q2 FY2024, at 2024-06-30$2.35bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092720.Report this figure2,379Total liabilities, Q3 FY2024, at 2024-09-30$2.38bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure2,435Total liabilities, FY2024, at 2024-12-31$2.44bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure2,323Total liabilities, Q1 FY2025, at 2025-03-31$2.32bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure2,322Total liabilities, Q2 FY2025, at 2025-06-30$2.32bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure2,173Total liabilities, Q3 FY2025, at 2025-09-30$2.17bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure2,209Total liabilities, FY2025, at 2025-12-31$2.21bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure1,674Total liabilities, Q1 FY2026, at 2026-03-31$1.67bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure1,661Total liabilities, Q2 FY2026, at 2026-06-30$1.66bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Long-term debt$m1,237Long-term debt, Q3 FY2023, at 2023-09-30$1.24bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-01, accession 0000950170-23-057414.Report this figure1,238Long-term debt, FY2023, at 2023-12-31$1.24bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-28, accession 0000950170-25-029973.Report this figure1,239Long-term debt, Q1 FY2024, at 2024-03-31$1.24bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-01, accession 0000950170-24-051234.Report this figure1,226Long-term debt, Q2 FY2024, at 2024-06-30$1.23bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-07, accession 0000950170-24-092720.Report this figure1,228Long-term debt, Q3 FY2024, at 2024-09-30$1.23bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure1,137Long-term debt, FY2024, at 2024-12-31$1.14bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figurenot reportednot reported141Long-term debt, Q3 FY2025, at 2025-09-30$140.5m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure829Long-term debt, FY2025, at 2025-12-31$829.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure838Long-term debt, Q1 FY2026, at 2026-03-31$838.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure848Long-term debt, Q2 FY2026, at 2026-06-30$847.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure
Current portion of debt$mnot reported105Current portion of debt, FY2023, at 2023-12-31$105.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-28, accession 0000950170-25-029973.Report this figure106Current portion of debt, Q1 FY2024, at 2024-03-31$105.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-01, accession 0000950170-24-051234.Report this figure91.5Current portion of debt, Q2 FY2024, at 2024-06-30$91.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092720.Report this figure91.6Current portion of debt, Q3 FY2024, at 2024-09-30$91.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-28, accession 0000950170-25-029973.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m764Shareholders' equity, Q3 FY2023, at 2023-09-30$764.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure859Shareholders' equity, FY2023, at 2023-12-31$859.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-02, accession 0001193125-26-084144.Report this figure961Shareholders' equity, Q1 FY2024, at 2024-03-31$961.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure1,077Shareholders' equity, Q2 FY2024, at 2024-06-30$1.08bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure1,221Shareholders' equity, Q3 FY2024, at 2024-09-30$1.22bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure1,528Shareholders' equity, FY2024, at 2024-12-31$1.53bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure1,190Shareholders' equity, Q1 FY2025, at 2025-03-31$1.19bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure1,405Shareholders' equity, Q2 FY2025, at 2025-06-30$1.40bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure1,320Shareholders' equity, Q3 FY2025, at 2025-09-30$1.32bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure1,141Shareholders' equity, FY2025, at 2025-12-31$1.14bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure1,505Shareholders' equity, Q1 FY2026, at 2026-03-31$1.51bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure1,528Shareholders' equity, Q2 FY2026, at 2026-06-30$1.53bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure

Cash flow

Operating cash flow$197.1m, Q2 FY2026
Capital expenditure$555.0k, Q2 FY2026
Share repurchases$0, Q4 FY2025
Sarepta Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(115)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$114.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122239. Derived: 9-month figure less the 6-month figure.Report this figure(54.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$54.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure(242)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$242.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure14.9Operating cash flow, Q2 FY2024, three months to 2024-06-30$14.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-103971. Derived: 6-month figure less the 3-month figure.Report this figure(70.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$70.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269436. Derived: 9-month figure less the 6-month figure.Report this figure92.0Operating cash flow, Q4 FY2024, three months to 2024-12-31$92.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure(583)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$583.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure261Operating cash flow, Q2 FY2025, three months to 2025-06-30$261.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335003. Derived: 6-month figure less the 3-month figure.Report this figure(14.6)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$14.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269436. Derived: 9-month figure less the 6-month figure.Report this figure131Operating cash flow, Q4 FY2025, three months to 2025-12-31$131.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure(203)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$202.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure197Operating cash flow, Q2 FY2026, three months to 2026-06-30$197.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335003. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m29.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$29.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122239. Derived: 9-month figure less the 6-month figure.Report this figure19.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$19.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure32.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$32.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure29.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$29.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-103971. Derived: 6-month figure less the 3-month figure.Report this figure37.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$37.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269436. Derived: 9-month figure less the 6-month figure.Report this figure38.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$38.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure43.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$43.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure31.8Capital expenditure, Q2 FY2025, three months to 2025-06-30$31.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335003. Derived: 6-month figure less the 3-month figure.Report this figure22.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$22.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269436. Derived: 9-month figure less the 6-month figure.Report this figure3.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$3.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figure2.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure0.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$555.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335003. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reported0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001193125-25-269436. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-06, accession 0001193125-25-269436. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-02, accession 0001193125-26-084144. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)105.43m, Q2 FY2026
Sarepta Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares87.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3087,628,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-01, accession 0000950170-23-057414.Report this figure88.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3188,186,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-01, accession 0000950170-24-051234.Report this figure88.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3088,743,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092720.Report this figure88.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3088,889,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122239.Report this figure99.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3199,114,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064412.Report this figure99.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3099,144,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-103971.Report this figure100Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30100,448,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure97.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3197,362,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure107Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30106,623,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure100Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30100,237,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269436.Report this figure122Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31121,916,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208893.Report this figure105Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30105,431,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure

Shares outstanding: 105.63mShares outstanding, period not labelled, at 2026-07-31105,627,021 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335003.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. Listed shows no prices and gives no investment advice.